GENEVA, Dec. 9 -- REPLIMUNE LIMITED (69 Innovation DriveMilton ParkOxford OX14 4RQ) filed a patent application (PCT/EP2025/065033) for "AN ONCOLYTIC HERPES SIMPLEX VIRUS (HSV) AND AN ANTI-PD-1 ANTIBODY FOR USE IN TREATING BRAF MUTANT MELANOMA" on May 30, 2025. With publication no. WO/2025/248110, the details related to the patent application was published on Dec 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): COFFIN, Robert Stuart (C/O Replimune Limited69 Innovation DriveMilton ParkAbingdon Oxfordshire OX14 4RQ)
Abstract: A method of treating BRAF mutant melanoma in a patient, including...